Higher placental anti-inflammatory IL-10 cytokine expression in HIV-1 infected women receiving longer zidovudine prophylaxis associated with nevirapine

• Main Authors: Sakorn Pornprasert, Jean Yves Mary, Albert Faye, Pannee Leechanachai, Aram Limtrakul, Sungwal Rugpao, Pannee Sirivatanapa, Vorapin Gomuthbutra, Wanmanee Matanasaravoot, Sophie Le Cœur, Marc Lallemant, Françoise Barré-Sinoussi, Elisabeth Menu, Nicole Ngo-Giang-Huong, Ahidjo Ayouba, Sanupong Chailert, Gérard Chaouat, Muriel Derrien, Guillermina Dolcini, Nicole Eteki, Anfumbom Jude Kfutwah, Odette Kouo, Brigitte Lemen, Juan Maldonado-Estrada, Eric Nerrienet, Bernadette Njinku, Gabriella Scarlatti, Mathurin Tejiokem, Gilbert Téné
• Format: Journal
• Published: 2018
• Subjects: Immunology and Microbiology; Medicine
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=64749097199&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/49141
• Institution: Chiang Mai University

Placental cytokine balance may be critical for the control of mother-to-child transmission (MTCT) of HIV. We assessed whether the type and duration of antiretrovirals used for prevention of HIV-1-MTCT modified the inflammatory cytokine profile. We investigated the levels of cytokine expression in the placentas of 61 HIV-1-infected women who received zidovudine (ZDV) plus single dose nevirapine (SD-NVP) or ZDV only for prevention of MTCT. Placentas of 38 HIV-1-uninfected women were included as controls. All placentas were obtained after vaginal delivery. Levels of mRNA and cytokine expression were quantified using real-time PCR and ELISA, respectively, in placental explants and 24-hour culture supernatants and analyzed in relation to the women's characteristics and the type and duration of antiretroviral prophylaxis. HIV-1-infected and uninfected women did not show any differences in the expression of placental cytokine secretion except for a trend toward lower TNF-10 mRNA levels in HIV-1-infected women. Within the HIV-1-infected group, women who were exposed to a long duration of ZDV (>72 days) or received SD-NVP less than 5h prior to delivery, more frequently expressed detectable levels of IL-10 in their placentas (32% versus 7% (p = 0.01) and 32% versus 5% (p = 0.02), respectively). No infant was found to be HIV-1-infected. Our results showed a normalization of the placental cytokine balance in HIV-1-infected women receiving antiretroviral prophylaxis. Furthermore, the type and duration of antiretroviral prophylaxis have an impact on the placental anti-inflammatory IL-10 expression level, which may contribute to controlling HIV replication at the placental level, thus reducing MTCT of HIV-1. © 2009 Bentham Science Publishers Ltd.